Cite
HARVARD Citation
Smith, H. et al. (2017). Prevention of allograft HCV recurrence with peri‐transplant human monoclonal antibody MBL‐HCV1 combined with a single oral direct‐acting antiviral: A proof‐of‐concept study. Journal of viral hepatitis. 24 (3), pp. 197-206. [Online].